# BridgeBio Pharma, Inc.: Form 4, filed Feb 17, 2021

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: 4
- Filed: 2021-02-17
- Accepted by EDGAR: Feb 17, 2021, 17:36 ET
- Period: 2021-02-17
- Accession: 0001140361-21-005267
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036121005267/xslF345X03/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036121005267/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036121005267/xslF345X03/form4.xml

Filed Feb 17, 2021.
Source: SEC EDGAR, the filing index for accession 0001140361-21-005267. Last ingested by Listed: Nov 3, 2026, 19:31 ET. No prices; not investment advice.